Prevention, treatment efforts reduce HIV infection among transgender women

February 18, 2019

Programs to prevent HIV in transgender women are helping to lower the rate of new infection but better care and treatment of this vulnerable population is still needed, especially among those of lower income or people of color, according to a new Rutgers study.

The study appears in the journal Sexually Transmitted Diseases.

"Despite the stability in HIV prevalence, infection is still highest among transwomen compared to any other group in the city - a pattern evident in much of the world," said lead author Henry Raymond, an associate professor at Rutgers School of Public Health and a core faculty member of Rutgers Global Health Institute. "San Francisco is on the cutting edge of HIV prevention, care and treatment, and there is extensive data from this city that is beneficial in monitoring the epidemic."

According to Raymond, transgender women generally have higher rates of HIV than other populations in the United States, including men who have sex with men, but no previous studies have implemented consistent methods or measures to document trends in HIV prevalence or demographic characteristics among transgender women over time.

"Since trends in San Francisco often are happening or likely to happen in other jurisdictions, studies like this could help provide data to guide appropriate epidemic responses," he said. "Such studies also can help cities assess if the trends seen in San Francisco are occurring in their area."

The researchers examined HIV prevalence over time - in 2010, 2013 and 2016 - among 866 transgender women in San Francisco, focusing on key demographic characteristics, including race/ethnicity, age, education, annual income, housing, their native country and gender identity. They also tested to determine HIV status and pre-exposure prophylaxis (PrEP) use within the last year.

On average, nearly one-third of the population of transwomen in San Francisco were infected with HIV from 2010 to 2016, with 90 percent having a confirmed diagnosis. Among the results, across all three waves of the study: Unstable housing has been linked to higher HIV risk and lower treatment, but the new study did not show a link between HIV infection and increased rates of homelessness or living in a shelter. Raymond said this could mean that housing assistance programs associated with HIV care are helping the most vulnerable of this population.

"While prevention programs such as outreach, condom distribution and increased HIV testing may be working to help reduce new cases of infection, our attention should now focus on maximizing the uptake and benefits of HIV care and addressing the challenging needs for stable housing," he said. "This could be done through continued promotion of HIV testing to link patients to care and treatment, using 'data-to-care' approaches to link transwomen to care and by bringing housing issues to the attention of housing advocates and city government."
-end-
To reach Raymond, contact Michelle Edelstein at 732-789-6555 or mse46@sph.rutgers.edu.

Rutgers University

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.